🇪🇺 Clinical Trials

Päivittyvä tietokanta EU:ssa tehtävästä ALS-tutkimuksesta. Linkki rekisteriin.

Viimeisimmät artikkelit

E
EU Clinical Trials Register RSS Feed
1 min lukuaika
Lukukerrat
11
EudraCT Number: 2010-022808-40 Sponsor Protocol Number: CANALS Sponsor Name: FONDAZIONE CENTRO S. RAFFAELE DEL MONTE TABOR Start Date: 2011-01-13 Medical condition: amyotrophic lateral sclerosis Disease: Version: 9.1 SOC Term: Classification Code: 10002026 Term: Level: PT Population Age...
E
EU Clinical Trials Register RSS Feed
1 min lukuaika
Lukukerrat
14
EudraCT Number: 2022-003050-32 Sponsor Protocol Number: FAB122-CT-2201 Sponsor Name: Ferrer Internacional S.A. Start Date: 2023-02-21 Medical condition: Amyotrophic Lateral Sclerosis (ALS) Disease: Population Age: Adults, Elderly Gender: Male, Female Trial Protocol: IT (Prematurely Ended), PL...
E
EU Clinical Trials Register RSS Feed
1 min lukuaika
Lukukerrat
11
EudraCT Number: 2020-003376-40 Sponsor Protocol Number: FAB122-CT-2001 Sponsor Name: Ferrer Internacional, S.A. Start Date: 2021-08-10 Medical condition: Amyotrophic Lateral Sclerosis Disease: Version: 21.1 SOC Term: 10029205 - Nervous system disorders Classification Code: 10002026 Term...
E
EU Clinical Trials Register RSS Feed
1 min lukuaika
Lukukerrat
8
EudraCT Number: 2019-001862-13 Sponsor Protocol Number: AB19001 Sponsor Name: ABScience Start Date: 2020-03-12 Medical condition: patients suffering from Amyotrophic Lateral Sclerosis (ALS) Disease: Version: 21.1 SOC Term: 10029205 - Nervous system disorders Classification Code: 10002026 Term...
E
EU Clinical Trials Register RSS Feed
1 min lukuaika
Lukukerrat
11
EudraCT Number: 2018-002373-22 Sponsor Protocol Number: hNSCALSII Sponsor Name: FONDAZIONE CASA SOLLIEVO DELLA SOFFERENZA OPERA DI SAN PIO DA PIETRELCINA OSPEDALE IRCCS Start Date: 2024-05-31 Medical condition: Amyotrophic Lateral Sclerosis (ALS) Disease: Population Age: Adults Gender: Male...
E
EU Clinical Trials Register RSS Feed
1 min lukuaika
Lukukerrat
9
EudraCT Number: 2020-005534-15 Sponsor Protocol Number: PRO-GLY-002/E2013 Sponsor Name: Proveca Pharma LTD Start Date: 2021-04-01 Medical condition: Severe sialorrhoea and neurodisabilties in children Disease: Population Age: Children, Adolescents, Under 18 Gender: Male, Female Trial Protocol...
Takaisin
Ylös